{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T06:47:31Z","timestamp":1775976451718,"version":"3.50.1"},"posted":{"date-parts":[[2025,9,17]]},"group-title":"In Review","reference-count":21,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,8,20]]},"abstract":"<title>Abstract<\/title>\n                <p>Background\nAlzheimer\u2019s disease and related dementias (ADRD) are growing public health concerns. Early and accurate differentiation between cognitively normal (NL), mild cognitive impairment (MCI), and dementia is essential for timely intervention. Structural MRI biomarkers\u2014such as grey matter volume (GMV), white matter volume (WMV), white matter hyperintensity volume (WMH), AD signature (a meta-region of interest), and hippocampal occupancy score (HOC)\u2014offer promise for objectively staging cognitive decline.\nObjective\nThis study aimed to evaluate the diagnostic utility of MRI-derived neuroimaging measures using receiver operating characteristic (ROC) curve analysis to identify optimal thresholds for distinguishing between NL, MCI, and dementia.\nMethods\nData were collected from 466 participants at the KU Alzheimer\u2019s Disease Research Center between 2010 and 2025. T1-weighted MRI scans were preprocessed using SPM12 and VBM12. Statistical analyses included ANOVA, Tukey\u2019s HSD, Welch\u2019s t-tests, and ROC analyses. Youden\u2019s J statistic was used to determine optimal cut-points, and multivariate models assessed combined biomarker performance.\nResults\nSignificant differences were found across diagnostic groups for GMV, WMH, AD signature, and HOC. ROC analysis for Demented vs the control group (NL) showed GMV had an AUC of 0.674 [0.6164, 0.7325], WMH an AUC of 0.700 [0.6454, 0.7539], AD signature an AUC of 0.829 [0.780, 0.8761], and HOC the highest individual performance with an AUC of 0.878 [0.8426, 0.9144]. Further ROC analysis confirmed AD signature and HOC as the most effective biomarkers (AUCs\u2009=\u20090.78 and 0.81) for distinguishing MCI\/demented from NL. In MCI vs. demented comparisons, AD signature and HOC biomarkers had AUCs of 0.70 and 0.73, respectively.\nConclusions\nMRI-derived biomarkers, particularly AD signature and HOC, show strong potential for differentiating cognitive impairment stages. ROC-based thresholds offer clinically actionable metrics that can improve diagnostic precision.<\/p>","DOI":"10.21203\/rs.3.rs-7418658\/v1","type":"posted-content","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T11:18:17Z","timestamp":1758107897000},"source":"Crossref","is-referenced-by-count":0,"title":["Structural Neuroimaging Markers of Dementia: Insights from ROC Curve Analysis"],"prefix":"10.21203","author":[{"given":"Sam","family":"Pepper","sequence":"first","affiliation":[{"name":"University of Kansas Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Setorwu","family":"Dzesu","sequence":"additional","affiliation":[{"name":"University of Kansas Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Yoksh","sequence":"additional","affiliation":[{"name":"University of Kansas Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankit","family":"Patel","sequence":"additional","affiliation":[{"name":"University of Kansas, University of Kansas Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robyn","family":"Honea","sequence":"additional","affiliation":[{"name":"University of Kansas, University of Kansas Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh Pal","family":"Mudaranthakam","sequence":"additional","affiliation":[{"name":"University of Kansas Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade","volume":"9","author":"Jack CR","year":"2010","unstructured":"Jack, C. R. Jr, et al. (2010). Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade. Lancet Neurology, 9(1), 119\u2013128.","journal-title":"Lancet Neurology"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: Recommendations from the National Institute on Aging\u2013Alzheimer\u2019s Association workgroups","volume":"7","author":"Sperling RA","year":"2011","unstructured":"Sperling, R. A., et al. (2011). Toward defining the preclinical stages of Alzheimer\u2019s disease: Recommendations from the National Institute on Aging\u2013Alzheimer\u2019s Association workgroups. Alzheimers Dement, 7(3), 280\u2013292.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","article-title":"The clinical use of structural MRI in Alzheimer disease","volume":"6","author":"Frisoni GB","year":"2010","unstructured":"Frisoni, G. B., et al. (2010). The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol, 6(2), 67\u201377.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/jnnp.71.4.441","article-title":"Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer\u2019s disease","volume":"71","author":"Du AT","year":"2001","unstructured":"Du, A. T., et al. (2001). Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer\u2019s disease. Journal Of Neurology, Neurosurgery And Psychiatry, 71(4), 441\u2013447.","journal-title":"Journal Of Neurology, Neurosurgery And Psychiatry"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"c3666","DOI":"10.1136\/bmj.c3666","article-title":"The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: Systematic review and meta-analysis","volume":"341","author":"Debette S","year":"2010","unstructured":"Debette, S., & Markus, H. S. (2010). The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: Systematic review and meta-analysis. Bmj, 341, c3666.","journal-title":"Bmj"},{"issue":"Pt 6","key":"ref6","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/brain\/119.6.2001","article-title":"Presymptomatic hippocampal atrophy in Alzheimer's disease","volume":"119","author":"Fox NC","year":"1996","unstructured":"Fox, N. C., et al. (1996). Presymptomatic hippocampal atrophy in Alzheimer's disease. Brain, 119(Pt 6), 2001\u20132007.","journal-title":"Brain"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nrneurol.2015.10","article-title":"White matter hyperintensities, cognitive impairment and dementia: An update","volume":"11","author":"Prins ND","year":"2015","unstructured":"Prins, N. D., & Scheltens, P. (2015). White matter hyperintensities, cognitive impairment and dementia: An update. Nat Rev Neurol, 11(3), 157\u2013165.","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"ref8","first-page":"904","article-title":"Cerebral autoregulation, white matter hyperintensities, and cognition in aging and dementia","volume":"75","author":"Brickman AM","year":"2010","unstructured":"Brickman, A. M., et al. (2010). Cerebral autoregulation, white matter hyperintensities, and cognition in aging and dementia. Neurology, 75(10), 904\u2013910.","journal-title":"Neurology"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1586\/ern.10.162","article-title":"Quantitative structural MRI for early detection of Alzheimer\u2019s disease","volume":"10","author":"McEvoy LK","year":"2010","unstructured":"McEvoy, L. K., & Brewer, J. B. (2010). Quantitative structural MRI for early detection of Alzheimer\u2019s disease. Expert Review Of Neurotherapeutics, 10(11), 1675\u20131688.","journal-title":"Expert Review Of Neurotherapeutics"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.jalz.2013.05.1769","article-title":"The Alzheimer\u2019s Disease Neuroimaging Initiative: A review of papers published since its inception","volume":"9","author":"Weiner MW","year":"2013","unstructured":"Weiner, M. W., et al. (2013). The Alzheimer\u2019s Disease Neuroimaging Initiative: A review of papers published since its inception. Alzheimers Dement, 9(5), e111\u2013e194.","journal-title":"Alzheimers Dement"},{"key":"ref11","first-page":"101970","article-title":"Revolution of Alzheimer precision neurology. Passageway of systems biology and neurophysiology toward the shift of clinical paradigms","volume":"198","author":"Hampel H","year":"2021","unstructured":"Hampel, H., et al. (2021). Revolution of Alzheimer precision neurology. Passageway of systems biology and neurophysiology toward the shift of clinical paradigms. Progress In Neurobiology, 198, 101970.","journal-title":"Progress In Neurobiology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nrneurol.2015.10","article-title":"White matter hyperintensities, cognitive impairment, and dementia: An update","volume":"11","author":".Prins ND","year":"2015","unstructured":".Prins, N. D., & Scheltens, P. (2015). White matter hyperintensities, cognitive impairment, and dementia: An update. Nature Reviews Neurology, 11, 157\u2013165.","journal-title":"Nature Reviews Neurology"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3233\/JAD-131928","article-title":"Multivariate data analysis and machine learning in Alzheimer\u2019s disease with a focus on structural magnetic resonance imaging","volume":"41","author":"Falahati F","year":"2014","unstructured":"Falahati, F., Westman, E., & Simmons, A. (2014). Multivariate data analysis and machine learning in Alzheimer\u2019s disease with a focus on structural magnetic resonance imaging. Journal of Alzheimer\u2019s Disease, 41(3), 685\u2013708.","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"5","key":"ref14","first-page":"547","article-title":"Impact of the Alzheimer\u2019s Disease Neuroimaging Initiative, 2004 to 2014","volume":"13","author":"Weiner MW","year":"2017","unstructured":"Weiner, M. W., et al. (2017). Impact of the Alzheimer\u2019s Disease Neuroimaging Initiative, 2004 to 2014. Alzheimer\u2019s & Dementia, 13(5), 547\u2013556.","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"2","key":"ref15","first-page":"569","article-title":"Tracking MRI markers of Alzheimer's Disease using machine learning","volume":"52","author":"Tosun D","year":"2016","unstructured":"Tosun, D., et al. (2016). Tracking MRI markers of Alzheimer's Disease using machine learning. Journal of Alzheimer\u2019s Disease, 52(2), 569\u2013582.","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"5","key":"ref16","first-page":"S400","article-title":"Estimating long-term cognitive decline from short-term data","volume":"10","author":"Donohue MC","year":"2014","unstructured":"Donohue, M. C., et al. (2014). Estimating long-term cognitive decline from short-term data. Alzheimer\u2019s & Dementia, 10(5), S400\u2013S410.","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1002\/hbm.22759","article-title":"Multimodal analysis of functional and structural disconnection in Alzheimer's disease using multiple kernel SVM","volume":"36","author":"Dyrba M","year":"2015","unstructured":"Dyrba, M., et al. (2015). Multimodal analysis of functional and structural disconnection in Alzheimer's disease using multiple kernel SVM. Human Brain Mapping, 36(6), 2118\u20132131.","journal-title":"Human Brain Mapping"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging\u2013Alzheimer\u2019s Association workgroups","volume":"7","author":"Albert MS","year":"2011","unstructured":"Albert, M. S., et al. (2011). The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging\u2013Alzheimer\u2019s Association workgroups. Alzheimer\u2019s & Dementia, 7(3), 270\u2013279.","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"1","key":"ref19","first-page":"19","article-title":"Recruitment and retention of participants for Alzheimer disease research","volume":"20","author":"Morris JC","year":"2006","unstructured":"Morris, J. C., et al. (2006). Recruitment and retention of participants for Alzheimer disease research. Alzheimer Disease & Associated Disorders, 20(1), 19\u201327.","journal-title":"Alzheimer Disease & Associated Disorders"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","article-title":"Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic","volume":"14","author":"Hampel H","year":"2018","unstructured":"Hampel, H., et al. (2018). Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nature Reviews Neurology, 14(11), 639\u2013652.","journal-title":"Nature Reviews Neurology"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden WJ","year":"1950","unstructured":"Youden, W. J. (1950). Index for rating diagnostic tests. Cancer, 3(1), 32\u201335.","journal-title":"Cancer"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7418658\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7418658\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T06:09:44Z","timestamp":1775974184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7418658\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":21,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-7418658\/v1","relation":{},"subject":[],"published":{"date-parts":[[2025,9,17]]},"subtype":"preprint"}}